US 9969705
Fused heterocyclic compound
granted A61PA61P1/02A61P1/04
Quick answer
US patent 9969705 (Fused heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P1/12, A61P1/16